Dogwood Therapeutics, Inc. (DWTX) Financials

DWTX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 80.5 million 12.1 million
March 31, 2026 95.2 million 14.6 million
Dec. 31, 2025 90.2 million 15.3 million
Sept. 30, 2025 92.0 million 14.6 million

DWTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.6 million ?
March 31, 2026 -4.6 million 449419
Dec. 31, 2025 -3.6 million 157860
Sept. 30, 2025 -3.3 million 48281

DWTX Net Income

No data available :(

DWTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 9.6 million - 69563
March 31, 2026 13.2 million - 144930
Dec. 31, 2025 6.5 million - 162604
Sept. 30, 2025 10.1 million - 120212

DWTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 34.1 million
March 31, 2026 33.5 million
Dec. 31, 2025 14.5 million
Sept. 30, 2025 1.9 million

DWTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3 3.2 million 1.6 million -
March 31, 2026 3 2.7 million 2.4 million -
Dec. 31, 2025 - 2.3 million 1.5 million -
Sept. 30, 2025 2 14.5 million 1.3 million -

DWTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 16686
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -

DWTX

Price: $1.22

52 week price:
1.22
9.50

Earnings Per Share: 1.96 USD

P/E Ratio: 1.09

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 49.1 million

Links: